A 2015 study first investigated cardiac biomarkers in SSc and although only 13 patients had associated PAH documented on RHC, increased hs-cTnT levels were independently associated with a higher risk of PAH in the multivariable analysis. The gene discussed is TNNT2; the disease is pulmonary arterial hypertension.